🌍July 4, 2026·1d agoResearch

Clinical immunogenicity and pharmacokinetic assessments of E3112, a recombinant human hepatocyte growth factor.

Publisher

Europe PMC

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: Europe PMC
Region: EU
Scope: Research
Published: July 4, 2026
Language: EN

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on europepmc.org

Leave the platform to read the original full article on the publisher site.

Source: Europe PMC

Scope: Research

Open original article

Related coverage

More related coverage

Crossref/18h ago

Three-Dimensional Preoperative Planning in Reverse Shoulder Arthroplasty: A Systematic Review of Implant Positioning Accuracy and Clinical Outcomes

Crossref/18h ago

Metabolomic Biomarkers for the Early Detection of Infectious Diseases: A Systematic Review and Meta-Analysis of Diagnostic Performance and Clinical Utility

Crossref/18h ago

Colistin Resistance in Klebsiella pneumoniae: Mechanisms, Detection, and Clinical Impact

Crossref/18h ago

Construction and Effectiveness Study of a Marketing Excellence System for Multinational Pharmaceutical Companies Under the Dual Drive of Compliance and Digitalization